Evidence map›Paper›PMID 20106900›Full record

ArticleCarcinogenesis2010

International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Therese Truong, Wiebke Sauter, James D McKay, H Dean Hosgood, Carla Gallagher, Christopher I Amos, Margaret Spitz, Joshua Muscat, Philip Lazarus, Thomas Illig and 43 more

Abstract read
In one paragraph

Article in Carcinogenesis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 7 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 7 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Role ofThe Journal of international medical research · 2021
    Pooled it
  2. Pooled it
  3. Effect of HLA-B-associated transcript 3 polymorphisms on lung cancer risk: a meta-analysis.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Pooled it
  4. BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. Pooled it
  6. Current evidences on IL1B polymorphisms and lung cancer susceptibility: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  7. Pooled it
  8. Review
  9. Acute myeloid leukemia with a novelLeukemia research reports · 2024
    Article
  10. Expression ofInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 13 countries.

Therese TruongInternational Agency for Research on Cancer, Lyon 69008, France.
Wiebke Sauter
James D McKay
H Dean Hosgood
Carla Gallagher
Christopher I Amos
Margaret Spitz
Joshua Muscat
Philip Lazarus
Thomas Illig
H Erich Wichmann
Heike Bickeböller
Angela Risch
Hendrik Dienemann
Zuo-Feng Zhang
Behnaz Pezeshki Naeim
Ping Yang
Shanbeh Zienolddiny
Aage Haugen
Loïc Le Marchand
Yun-Chul Hong
Jin Hee Kim
Eric J Duell
Angeline S Andrew
Chikako Kiyohara
Hongbing Shen
Keitaro Matsuo
Takeshi Suzuki
Adeline Seow
Daniel P K Ng
Qing Lan
David Zaridze
Neonilia Szeszenia-Dabrowska
Jolanta Lissowska
Peter Rudnai
Eleonora Fabianova
Vali Constantinescu
Vladimir Bencko
Lenka Foretova
Vladimir Janout
Neil E Caporaso
Demetrius Albanes
Michael Thun
Maria Teresa Landi
Joanna Trubicka
Marcin Lener
Jan Lubinski
EPIC-lung
Ying Wang
Amélie Chabrier
Paolo Boffetta
Paul Brennan
Rayjean J Hung
Centre international de recherche sur le cancer · FRHelmholtz Zentrum München · DEInternational Hereditary Cancer Center · PLNational Institutes of Health · USPenn State Milton S. Hershey Medical Center · USAichi Cancer Center · JPDartmouth College · USNational Cancer Institute · USNational Institute of Occupational Health · NONational University of Singapore · SGSeoul National University · KRThe University of Texas MD Anderson Cancer Center · USUniversity of California, Los Angeles · USAmerican Cancer Society · USCharles University · CZGerman Cancer Research Center · DEHeidelberg University · DEInserm · FRKyushu University · JPMasaryk Memorial Cancer Institute · CZ

Funding

SEA Influenza Clinical Research NetworkN01CO12400 · NCI · LEIDOS BIOMEDICAL RESEARCH, INC. · 2007 to 2008
$225.2M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2003 to 2011
$21.9M
UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
PROSTATE, LUNG, COLORECTAL, &OVARIAN CANCER SCREENINGN01CN025476 · CN · WESTAT, INC. · PI O'BRIEN, BARBARA B · 1992 to 2000
$7.9M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
ALPHA 1 AD CARRIERS AND LUNG CANCER RISKR01CA080127 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2000 to 2009
$4.4M
Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
Inflammation Genes and Lung Cancer RiskR01CA127219 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2008 to 2013
$3.1M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
CCR NIH HHS N01-RC-37004CCR NIH HHS N01-RC-45035Intramural NIH HHSMedical Research Council G0401527NCI NIH HHS CA121197NCI NIH HHS CA127219NCI NIH HHS CA55769NCI NIH HHS CA80127NCI NIH HHS CA84354NCI NIH HHS K07 CA104231NCI NIH HHS K99 CA131477NCI NIH HHS N01-CN-25404NCI NIH HHS N01-CN-25476NCI NIH HHS N01-CN-25511NCI NIH HHS N01-CN-25512NCI NIH HHS N01-CN-25513NCI NIH HHS N01-CN-25514NCI NIH HHS N01-CN-25515NCI NIH HHS N01-CN-25516NCI NIH HHS N01-CN-25518NCI NIH HHS N01-CN-25522NCI NIH HHS N01-CN-25524NCI NIH HHS N01-CN-45165NCI NIH HHS N01-CN-75022NCI NIH HHS N01 CO12400NCI NIH HHS P01 CA068384NCI NIH HHS P01 CA68384NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA080127NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R03 CA133939NCI NIH HHS R03 CA133939-01NCRR NIH HHS P20RR018787NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01HG004438NHGRI NIH HHS U01 HG004446NHLBI NIH HHS R01HL091172-01PHS HHS HG-06-033-NCI-01
6 · The paper itself

Abstract

backgroundAnalysis of candidate genes in individual studies has had only limited success in identifying particular gene variants that are conclusively associated with lung cancer risk. In the International Lung Cancer Consortium (ILCCO), we conducted a coordinated genotyping study of 10 common variants selected because of their prior evidence of an association with lung cancer. These variants belonged to candidate genes from different cancer-related pathways including inflammation (IL1B), folate metabolism (MTHFR), regulatory function (AKAP9 and CAMKK1), cell adhesion (SEZL6) and apoptosis (FAS, FASL, TP53, TP53BP1 and BAT3).

methodsGenotype data from 15 ILCCO case-control studies were available for a total of 8431 lung cancer cases and 11 072 controls of European descent and Asian ethnic groups. Unconditional logistic regression was used to model the association between each variant and lung cancer risk.

resultsOnly the association between a non-synonymous variant of TP53BP1 (rs560191) and lung cancer risk was significant (OR = 0.91, P = 0.002). This association was more striking for squamous cell carcinoma (OR = 0.86, P = 6 x 10(-4)). No heterogeneity by center, ethnicity, smoking status, age group or sex was observed. In order to confirm this association, we included results for this variant from a set of independent studies (9966 cases/11,722 controls) and we reported similar results. When combining all these studies together, we reported an overall OR = 0.93 (0.89-0.97) (P = 0.001). This association was significant only for squamous cell carcinoma [OR = 0.89 (0.85-0.95), P = 1 x 10(-4)].

conclusionThis study suggests that rs560191 is associated to lung cancer risk and further highlights the value of consortia in replicating or refuting published genetic associations.

Indexed as

Genetic Predisposition to DiseaseAdultAgedFemaleGenome-Wide Association StudyGenotypeHumansIntracellular Signaling Peptides and ProteinsLung NeoplasmsMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedMolecular ChaperonesOdds RatioTumor Suppressor p53-Binding Protein 1BAG6 protein, humanIntracellular Signaling Peptides and ProteinsMethylenetetrahydrofolate Reductase (NADPH2)Molecular ChaperonesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID20106900
PMCPMC2847090
OpenAlexW2116169630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.